AUPH: Aurinia Pharmaceuticals Company Short-Term Debt
Aurinia Pharmaceuticals (AUPH) is implementing automation in drug packaging and testing robots for protein analysis. The delivery of treatments for autoimmune pathologies is ensured by strict control of transportation conditions, and the indicator is 0.02. The price trajectory shown below confirms that the business relies on an asset-light model, outsourcing the production of nephritis treatments to Lonza plants, which makes the company dependent on external suppliers.
Metric breakdowns and analytics for Aurinia Corp (AUPH)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Aurinia Pharmaceuticals|AUPH - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Aurinia Pharmaceuticals|AUPH - Company Total Debt|Debt to Book Capitalization Ratio Aurinia Pharmaceuticals Inc.|AUPH - Company Long-Term Liabilities|Company Current Liabilities Aurinia Pharmaceuticals|Quick Liquidity auriniapharma.com
- net income and valuation multiples indicators:
Initial company analysis:AUPH - Aurinia Pharmaceuticals Inc.
The Aurinia Pharmaceuticals (AUPH) business model relies on the high margins of its exclusive kidney treatment drug. By analyzing short-term borrowing levels on GURU.Markets, an investor assesses the volume of liabilities maturing within one year. This metric measures liquidity and the company's ability to service urgent loans without disrupting operational activities. An increase in this indicator may signal preparations for scaling distribution. A stable debt balance confirms the financial stability of the asset.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|BCRX - Company Short-Term Debt|veratx.com (VERA) - Company Current Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|Company Current Liabilities ABCL|Company Short-Term Debts Tourmaline|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|Zenas Biopharma, Inc. - Company Short-Term Debts|IMNM - Company Short-Term Debts|GOSS (Gossamer Bio, Inc.) - Company Current Liabilities|kalvista.com (KALV) - Company Short-Term Debts|Company Short-Term Debt Septerna|PVLA: Company Short-Term Loans and Borrowings|Company Short-Term Debts SVRA|Short-Term Debt Volume Rigel Corp|Company Short-Term Debt AnaptysBio, Inc. ANAB|ATXS: Company Short-Term Indebtedness|enGene - Company Short-Term Debts|Short-Term Debt Volume rapt.com RAPT|JBIO: Company Short-Term Debts|Aclaris Therapeutics, Inc (ACRS) - Company Short-Term Debts|Company Current Liabilities KYTX|TLSA: Company Short-Term Loans and Borrowings|Company Short-Term Debt Cabaletta Bio (CABA)|VTYX: Current Liabilities|Company Short-Term Debts THTX (Theratechnologies Inc)|Company Short-Term Loans and Borrowings AVTX|Eledon Pharmaceuticals - Company Short-Term Debts|AGEN - Company Short-Term Debts|Climb Bio (CLYM) - Company Short-Term Debt|zurabio.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt aTyr|Company Current Liabilities Adagene Corp (ADAG)|Company Short-Term Debts IMA|Company Short-Term Debts shattucklabs.com (STTK)|Company Short-Term Debts EQ (Equillium)|CNTB - Company Current Liabilities|Immunic Inc - Company Short-Term Debts|Short-Term Debt Atara Biotherapeutics|IFRX (inflarx.de) - Company Current Liabilities|x4pharma.com (XFOR) - Company Short-Term Debts|Company Current Liabilities ACET|CELU (Celularity Corp) - Amount of Current Liabilities|Company Short-Term Debts INMB|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debts KZR (Kezar Life Sciences)|SABS - Company Current Liabilities|Akari Therapeutics Plc - Company Short-Term Debts|ENLV - Company Short-Term Debts|q32bio.com (QTTB) - Company Short-Term Debt|GOVX (GeoVax Corp) - Company Short-Term Debt|Company Short-Term Debt Edesa Biotech, Inc.|ibioinc.com (IBIO) - Short-Term Debt Volume|Company Short-Term Debts CARM|Company Short-Term Debts XTL Biopharmaceuticals Ltd (XTLB)|Bolt Biotherapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts HCW Biologics, Inc. HCWB|APVO - Company Short-Term Debt|Current Liabilities AIM|ADTX: Company Short-Term Debts|GRI Bio Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt XORTX|Vyome Therapeutics - Current Liabilities|Company Short-Term Debts REVB|INDP (indaptusrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|AFMD - Company Short-Term Debt|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debts Ocean Biomedical Inc|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|THRD (Third Harmonic Bio Inc) - Company Short-Term Loans and Borrowings